Artigas SJR, Rodríguez MM, Posada FPE, Rodríguez VIM

Language: Spanish
References: 10
Page:
PDF size: 55.06 Kb.

ABSTRACT

A retrospective, observational and cohort investigation was carried out during 14 years to determine the effectiveness of the meningococcal B-C vaccine applied in the vaccinated and not vaccinated cohort from 1996 to 2009. The study universe was represented by the total of vaccinated and not vaccinated live births from 1996 to 2009 constituted in two cohorts of vaccinated and not vaccinated with the meningococcal B-C vaccine and that were followed until they were 10 years. The information compilation technique was by means of compulsory declared cards and clinical records of notified cases, looking for the vaccination antecedents. The results were represented in tables and the information was analyzed determining the effectiveness by vacunal cover, relative risk and population preventable fraction. The main results were: the risk of becoming ill in the cohorts population of vaccinated and not vaccinated during the study period is very low and the Cuban vaccine VA-MENGOC-BC reaches a high protection in the childhood. Only the group of 5 to 9 years shows the high-risk value although with magnitude of protection.

REFERENCES

1. Quintana López L, Serrano Jerez J, Guerrero Jiménez G, Rodríguez López A. Caracterización de los pacientes ingresados por meningoencefalitis: 1995-2001. Arch Med Camagüey [Internet]. 2003 [citado 10 Jul 2010]; 7(5): 25-32. Disponible en: http://www.amc.sld.cu/amc/2003/v7supl1/781.pdf

2. Delgado Ross F, Rubio Rodríguez A, Hernández Pupo A. Morbimortalidad por meningoencefalitis bacteriana, Hospital General Docente “Vladimir Ilich Lenin”, Holguín, 2000- 2004. Correo Cient Med Holguín [Internet]. 2006 [citado 10 Jul 2010]; 10(1): 21-30. Disponible en: http://www.cocmed.sld.cu/no101/n101ori6.htm

3. Roos KL, Tyler KL. Meningitis bacterianas y otras infecciones supurativas. En: Bravawald E, Hauser SL, Fruti AS, Longo DL, Lasper DL, Jamerson JL. editores. Principios de Medicina Interna. 15 ed. Madrid: McGraw Hill; 2002. p. 2880-2892.

4. Sierra VG, Campa C, Valcárcel M, Sotolongo F, Figueredo L. Efficacy evaluation of the Cuban vaccine VA-MENGOC-BC against disease caused by serogrupo B Neisseria meningitidis. En: Markachtman C, et al., editors. Neisseriae 1990. Proceedings of the Seventh International Conference on Pathogen Neisserias; 1990 Sept. 9-14; Berlin, Federal Republic of Germany. Berlín: Walter Dgruyter, 1991:129.

5. Ortegas Verdecia BP. Búsqueda de portadores. Rev Cubana Hig Epidemiol. 1978; 16(2): 123-128.

6. Artigas Serpa JR, Borges Acosta O. Eficacia postlicenciamiento de la vacuna antimeningocóccica B-C cubana en la población de 0 a 24 años de la provincia de Ciego de Ávila. 1993. [documento no publicado]

7. Dickinson Meneses FO, Pérez Rodríguez AE. Las meningoencefalitis bacterianas en la población infantil cubana: 1998-2000. Rev Cubana Pediatr [Internet]. 2002 [citado 10 Jul 2010]; 74(2): 106-114. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312002000200002&lng=es&nrm=iso

8. Rico Cordeiro O. Eficacia postlicenciamiento de la vacuna antimeningocóccica B-C en menores de 6 años de la provincia Holguín. Informe Técnico, 1992. [documento no publicado]

9. Costa EA. Relatoria sobre a avaliacao da eficacia da vacina antimeningócoca BC de origem cubana. Inf Epidemiol SUS. 1994; 2:7-32.

10. Echeverry ML. Efectividad de la vacuna antimeningocóccica en una cohorte de Itagui, Colombia. Bol Epidemiol Antioquia. 1995; 2: 47-51.